All posts by medical

ImmuneID Appoints Annalisa D’Andrea as President and Chief Scientific Officer – Business Wire

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ImmuneID, Inc., a precision immunology company employing a proprietary platform to identify and therapeutically target antibody interactions that drive immune diseases, today announced that Annalisa DAndrea, Ph.D., has been appointed President and Chief Scientific Officer. Dr. DAndrea brings more than 25 years of experience in translational research in immunology to ImmuneID.

The addition of Annalisa as President and CSO is an important milestone for ImmuneID, as the company applies its platform to identify promising immunological therapeutic targets, said Stephen Elledge, Ph.D., ImmuneID co-founder and Chair of ImmuneID SAB, Lasker Award winner, and The Gregor Mendel Professor of Genetics and Medicine, Harvard Medical School. Annalisas experience advancing drug candidates to the clinic will be extremely valuable and I look forward to working with her.

Annalisa brings significant drug development experience that will be extremely valuable as the company works to develop therapeutic candidates to treat patients in a range of disease areas, such as oncology, autoimmune diseases, severe allergies, and infectious diseases, said Longwood Funds Christoph Westphal, M.D., Ph.D., ImmuneID co-founder and Executive Chair.

The announcement of Dr. DAndrea as President and CSO follows the launch of the company last year with a $22M seed financing led by founding investor Longwood Fund. Participants in the financing included Arch Venture Partners, Pitango HealthTech, Alta Partners, In-Q-Tel, Xfund, and others. ImmuneID plans to use this funding to develop therapeutic programs in areas including severe allergy, autoimmunity, oncology, and infectious disease.

ImmuneIDs platform enables rapid and accurate scanning of a patients immunological history and holds significant promise to generate information that will elucidate disease patterns and patient responses. This information will guide us in the discovery and development of new therapeutics related to immune diseases, DAndrea said. I am thrilled to join ImmuneID at this stage as we build a talented scientific team and lead the companys scientific growth.

In addition to her appointment at ImmuneID, Dr. DAndrea joins the Longwood Fund as a Venture Partner.

Previously, Dr. DAndrea was Chief Scientific Officer of Kiniksa Pharmaceuticals. Before joining Kiniksa, DAndrea was Vice President and Global Head of Discovery for Immunology and Inflammation at Roche, where she was responsible for discovering and advancing multiple drug candidates to the clinic. Prior to Roche, she was Executive Director and Section Head of Discovery Biology at SRI International, where she was responsible for developing strategies to advance drugs through discovery and into development. Dr. DAndrea received a Bachelor of Sciences, summa cum laude, from the University of Siena in Italy and a doctoral degree from the University of Florence while training at the Wistar Institute at the University of Pennsylvania.

About ImmuneID

ImmuneID is a precision immunology company using its proprietary platform to simultaneously identify and therapeutically target millions of antibody interactions that drive immune diseases. Based on technology developed by scientific founders Stephen Elledge (Harvard), Ben Larman (Johns Hopkins), and Tomasz Kula (Harvard), we are employing our massively parallel, multiplexed, and unbiased systems to develop therapeutics for autoimmunity, severe allergy, oncology and infectious disease. ImmuneID was founded in 2020 by Longwood Fund and is headquartered in Cambridge, MA.

Go here to see the original:
ImmuneID Appoints Annalisa D'Andrea as President and Chief Scientific Officer - Business Wire

Chronic Viral Infections Can Have Profound Lasting Effects on Human Immunity, Similar to Aging – SciTechDaily

Network topology analysis of immune system function representing dozens of integrated cellular responses that are rewired during removal of the hepatitis C virus in humans. Different communities (functional clusters, colored) are determined by the signaling pathways that are being interrogated. For example, the black community observed during active HCV infection is largely configured by MAPK activity; shrinks with the decrease in viremia, and disappears after complete viral clearance. A nascent blue population mid-treatment configured by proliferation/survival/differentiation (P/S/D)/STAT1 signaling activities (largely anti-viral) expands post sofosbuvir treatment. Credit: Dr. David Furman

Researchers identify signatures of immune dysfunction that are shared in aging and chronic viral infections of HIV and Hepatitis C.

Research from the Buck Institute and Stanford University suggests that chronic viral infections have a profound and lasting impact on the human immune system in ways that are similar to those seen during aging. Results are published in Proceedings of the National Academy of Sciences.

Using systems immunology and artificial intelligence, researchers profiled and compared immune responses in a cohort of aging individuals, people with HIV on long-term anti-retroviral therapy, and people infected with hepatitis C (HCV) before and after the virus was treated with a drug that has up to a 97% cure rate. Shared alterations in the immune system include T cell memory inflation, upregulation of intracellular signaling pathways of inflammation, and diminished sensitivity to cytokines in lymphocytes and myeloid cells.

Chronic inflammation stemming from immune system dysfunction is associated with many of the diseases of aging, says David Furman, PhD, Buck Institute associate professor and senior author of the paper. Whether chronic viral infection contributes to age-associated immune dysfunction is still an open question, but studies of this type provide a way to start getting answers. At this point its clear that both aging and chronic viral infections leave profound and indelible marks on immunity.

In acute viral infections the body is usually able to clear the offending agent and the immune system (in the best-case scenario) produces antibodies that protect against similar infections think of common colds and seasonal flus. But there are viruses, in addition to HIV and HCV, which can remain alive, setting up host-parasite housekeeping in the body, in some cases without people being aware of them. Furman says depending on geographic location, 70 to 90% of the population is infected with cytomegalovirus, which is harmless in healthy individuals and is only problematic for pregnant women or those with compromised immune systems. Various herpes viruses (which cause genital herpes, cold sores, chicken pox/shingles, and mononucleosis) can also lead to chronic infections.

Each of us has our own virome; its the collection of the viral infections you have during your lifespan, Furman says. You probably have been infected by 12 or 15, or even more viruses that you never knew you had. Fortunately technology now exists that allows us to profile these infections in the human population; it is helping us move these types of inquiries forward. Furman says this study is the first to fully incorporate the concept of systems immunology and holistically analyze the immune system using the same technological platforms across different cohorts of patients.

The study showed that in patients with HIV, immune system dysregulations were evident despite having been treated with virus-suppressing drugs for over ten years. But clearance of the HCV virus (via the drug sofosbuvir) partially restored cellular sensitivity to interferon-a, which inhibits viral replication. This plasticity means there is room for intervention in both chronic viral infections and in aging, says Furman. Its just a matter of identifying and understanding the molecular pathways and networks involved. This paper identified changes in STAT1, the primary transcription factor activated by interferons. STAT1 plays a major role in normal immune responses, particularly to viral, mycobacterial and fungal pathogens.

Furman says we are in the midst of an ongoing living experiment in regards to the COVID-19 pandemic. He says future studies are needed to determine whether the functional imprinting of the immune system is hardwired to only involve the chronic nature of specific infections, or whether relatively short-lived but vigorous inflammations such as COVID-19 also leave a long-lasting footprint on the immune system. Has the immune system of those infected with the coronavirus taken a big hit? Thats a theory, but we dont know what will happen, says Furman, who is collaborating with Stanford University and the University of California, San Francisco on projects involving COVID-19 and immunity.

Reference: Signatures of immune dysfunction in HIV and HCV infection share features with chronic inflammation in aging and persist after viral reduction or elimination by Cesar J. Lopez Angel, Edward A. Pham, Huixun Du, Francesco Vallania, Benjamin J. Fram, Kevin Perez, Thai Nguyen, Yael Rosenberg-Hasson, Aijaz Ahmed, Cornelia L. Dekker, Philip M. Grant, Purvesh Khatri, Holden T. Maecker, Jeffrey S. Glenn, Mark M. Davis and David Furman, 2 April 2021, Proceedings of the National Academy of Sciences.DOI: 10.1073/pnas.2022928118

Other Buck Institute collaborators include Huixan Du and Kevin Perez. Additional co-authors include Cesar J. Lopez Angel, Edward A. Pham, Benjamin J. Fram, Thai Nguyen, Yael Rosenberg-Hassan, Holden T. Maecker, Jeffrey S. Glenn, and Mark M. Davis, Department of Microbiology and Immunology, Stanford University School of Medicine, Palo Alto, CA; Francesco Vallania, Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine; Aijaz Ahmed, Division of Gastroenterology and Hepatology, Stanford University School of Medicine; Purvesh Khatri, Stanford Center for Biomedical Informatics Research, Stanford University School of Medicine; Cornelia L. Dekker, Department of Pediatrics, Division of Infectious Diseases, Stanford University School of Medicine; and Philip M. Grant, Division of Infectious Diseases, Department of Medicine, Stanford University School of Medicine.

Follow this link:
Chronic Viral Infections Can Have Profound Lasting Effects on Human Immunity, Similar to Aging - SciTechDaily

Cetirizine Hydrochloride Market Is Projected to Be Around US$ 1.4 Billion With Healthy CAGR of 3.2% – PharmiWeb.com

SEATTLE, April 09, 2021, (PHARMIWEB) Cetirizine hydrochloride belongs to the antihistamine drug class which reduces the natural chemical, histamine, in the body. Histamine induces symptoms such as sneezing, watery eyes, and runny nose. Cetirizine hydrochloride is used for treating cold, allergy symptoms, itching and swelling caused by hives. It is available on prescription, however, it is also available over-the-counter in pharmacies and supermarkets.

The global cetirizine hydrochloride market size was valued at US$ 1,100 million in 2017, and is expected to exhibit a robust CAGR of 3.2% over the forecast period (2018 2026).

The global cetirizine hydrochloride market growth is expected to be driven by increasing incidence of allergic conditions such as allergic rhinitis, allergic conjunctivitis, and eczema.

*The Download PDF brochure only consist of Table of Content, Research Framework, and Research Methodology.

Request PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2069

Figure 1. Global Cetirizine Hydrochloride Market Value (US$ Mn), by Region, 2017

Source: Coherent Market Insights Analysis (2018)

Increasing incidence of allergic rhinitis is expected to drive growth of the market

High prevalence of allergic conditions such as allergic rhinitis, also known as hay fever, is expected to propel growth of the cetirizine hydrochloride market. According to the American Academy of Allergy Asthma and Immunology, 2015, allergic rhinitis affects around 10 to 30% of the population worldwide. Moreover, according to the International Study of Asthma and Allergies in Childhood (ISAAC), 2016, the prevalence of pollen allergy or hay fever in children between the age group of 12-14 years was 22.1% worldwide, registering the highest rate of 33.3% in North America.

North America holds a dominant position in the global cetirizine hydrochloride market, owing to the high prevalence of hay fever and allergic conjunctivitis in the U.S. According to the American Academy of Allergy Asthma and Immunology, around 7.8% of the U.S. population aged 18 and above suffers from hay fever. The National Health Interview survey of 2016 further stated that around 6.5% (or 16.0 million) adults and 7.5% (or 5.5 million) children under 18 years of age were diagnosed with hay fever in 2015.

Moreover, the cetirizine hydrochloride market in North America is expected to witness significant growth owing to the increasing economic burden caused due to allergic diseases on the affected population. According to the American College of Allergy, Asthma and Immunology, in 2018, allergies were the sixth leading cause of chronic illness in the U.S., with over 50 million people suffering from allergies annually, which accounted for an expenditure of US$ 18 billion.

However, the drug can induce severe to moderate side effects which include insomnia, hyperactivity, uneven heartbeat, nausea, constipation, and headache, which is expected to limit the adoption of the drug and hamper the market growth.

Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendationsBuy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/2069

Figure 2. Global Cetirizine Hydrochloride Market Share (%), by Dosage Form, 2018 and 2026

Source: Coherent Market Insights Analysis (2018)

Increasing incidence of allergic eye symptoms and eczema is expected to propel the market growth

The growing risk of developing allergic eye conditions with the onset of allergic rhinitis or hay fever is also a major factor driving the market growth. According to a survey conducted by the Virtual Medical Center, around 97% children diagnosed with allergic rhinitis or hay fever also have allergic eye symptoms. Moreover, the survey stated that around 56% children with asthma experience allergic eye symptoms, whereas 33% of children with eczema have allergic eye symptoms. The signs and symptoms include redness of eyes, excessive watering, itchy burning eyes, discharge, blurred vision and increased sensitivity to light. Furthermore, according to a study published in Clinical Review and Education Journal in 2013, around 40% of the global population suffered from allergic conjunctivitis.

According to the Nutrition and Health Department, in 2015, atopic dermatitis (AD) or atopic eczema, is a common chronic inflammatory skin disease affecting 15-20% of children and 1-3% of adults worldwide. Thus, the increasing prevalence of allergic conjunctivitis and eczema is a major factor driving the market growth.

Key players in the market are focused on new product launches to enhance the market share. For instance, in 2014, McNeil Consumer Healthcare a Johnson and Johnson Company launched a convenient oral, dissolvable tablet to the Zyrtec portfolio of allergy-relief products.

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/cetirizine-hydrochloride-market-to-surpass-us-14-billion-by-2026-1089

Major players operating in the global cetirizine hydrochloride market include, Johnson and Johnson, Mylan, Inc., Nicox S.A., Strides Shasun, Apotex, Inc., Teva UK Limited, Aurobindo Pharma Limited, Jubilant Life Sciences, Tris Pharma, Inc., and Cipla Ltd.

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website http://www.coherentmarketinsights.com

Contact:

Coherent Market Insights1001 4th Ave, #3200 Seattle, WA 98154, U.S.Email:sales@coherentmarketinsights.comUnited States of America: +1-206-701-6702United Kingdom: +44-020-8133-4027Japan: +050-5539-1737India: +91-848-285-0837

Read the original:
Cetirizine Hydrochloride Market Is Projected to Be Around US$ 1.4 Billion With Healthy CAGR of 3.2% - PharmiWeb.com

Computational Immunology Market 2021 Is Rapidly Increasing Worldwide in Near Future | Top Companies Analysis- EpiVax, Novozymes Biopharma, ioGenetics,…

A detailed report entitled, Global Computational Immunology Market recently published by DataIntelo offers a comprehensive outlook of the global Computational Immunology market. It is an all-inclusive report that provides lucid and precise information about the crucial aspects of key components and players of the market. The report offers a robust assessment of the Computational Immunology market to understand the scope of the growth potential, revenue growth, product range, and pricing factors besides analysis the market size, market performance, and market dynamics of the Computational Immunology market. Moreover, the report is thoroughly assessed to draw a broader picture of the market by a detailed study of the current market trend and examines the potential expansion and growth of the Computational Immunology market during the forecast period, 2020-2027.

Key companies that are covered in this report:

EpiVaxNovozymes BiopharmaioGeneticsInternational Society of VaccinesIMGTDassault SystemesCertaraChemical Computing GroupCompugenGenedata AGInsilico Biotechnology AGLeadscope IncNimbus DiscoveryStrand Life SciencesSchrodingerSimulation PlusRosa & Co

*Note: Additional companies can be included on request

Get Free Exclusive PDF Sample Of This Report: https://dataintelo.com/request-sample/?reportId=217714

The report has an exclusive chapter on the COVID-19 pandemic and its major impact of the manufacturing of products and other services related to the market. It also makes a concrete assessment of the potential impact of the ongoing COVID-19 in the next coming years. With this information, the report aims to assist clients to formulate an effective market strategies and investment plan to make a change in their business outlook. Moreover, the report covers key strategies and plans adopted by some major players to ensure their market presence and to remain intact in the global competition.

This market report provides a holistic view about the market dynamics and overall outlook through providing a concrete explanation about key drivers, restrains, opportunities, and challenges in the coming years. It also offers key insight about the current market trend and performance in respect to various products associated with the market. It also highlights key insights on which component is expected to expand significantly and which region is emerging as the key potential destination of the Computational Immunology market. Moreover, it provides a critical assessment of the emerging competitive landscape of the manufacturers as the demand for the Computational Immunology is projected to increase substantially across the different regions.

The report, published by DataIntelo, is the most accurate and reliable information due to its wide research activities from a dedicated team. The report is prepared using a robust research methodology focusing on primary as well as secondary sources. The report is prepared by relying on primary source including interviews of the company executives & representatives and accessing official documents, websites, and press release of the companies. The DataIntelos report is widely known for its accuracy and factual figures as it consists of a concise graphical representations, tables, and figures which displays a clear picture of the developments of the products and its market performance over the last few years.

You can buy the complete report in PDF format @ https://dataintelo.com/checkout/?reportId=217714

You can also go for a yearly subscription of all the updates on Computational Immunology market.

The report covers a detailed performance of some of the key players and analysis of major players in the industry, segments, application and regions. Moreover, the report also takes into account the governments policies in the evaluation of the market behavior to illustrate the potential opportunities and challenges of the market in each region. The report also covers the recent agreements including merger & acquisition, partnership or joint venture and latest developments of the manufacturers to sustain in the global competition of the Computational Immunology market.

By Types:

Cancer Diagnosis & TherapyReverse VaccinologyImmune System Modeling

By Applications:

Allergy Prediction DatabasesAnalysis Resource DatabaseInternational Immunogenetics SystemThe Ontology Of Immune EpitopesImmune Epitope Database

As per the estimation of DataIntelo, the global Computational Immunology market was valued at UDS XX million and is projected to reach a value of USD XX million by the end of 2027, expanding at a CAGR of XX% through the forecast period. The report covers the performance of the Computational Immunology in regions, North America, Latin America, Europe, Asia Pacific, and Middle East & Africa by focusing some key countries in the respective regions. As per the clients requirements, this report can be customized and available in a separate report for the specific region and countries.

The following is the TOC of the report:

Executive Summary

Assumptions and Acronyms Used

Research Methodology

Computational Immunology Market Overview

Global Computational Immunology Market Analysis and Forecast by Type

Global Computational Immunology Market Analysis and Forecast by Application

Global Computational Immunology Market Analysis and Forecast by Sales Channel

Global Computational Immunology Market Analysis and Forecast by Region

North America Computational Immunology Market Analysis and Forecast

Latin America Computational Immunology Market Analysis and Forecast

Europe Computational Immunology Market Analysis and Forecast

Asia Pacific Computational Immunology Market Analysis and Forecast

Asia Pacific Computational Immunology Market Size and Volume Forecast by Application

Middle East & Africa Computational Immunology Market Analysis and Forecast

Competition Landscape

Customize Report and Inquiry for the Computational Immunology market report @ https://dataintelo.com/enquiry-before-buying/?reportId=217714

Why you should buy this report?

The report also answers some of the key questions given below:

About DataIntelo:

We keep our priority to fulfil the needs of our customers by offering authentic and inclusive reports for the global market-related domains. With a genuine effort from a dedicated team of business experts, DataIntelo has been in the service by providing innovative business ideas and strategies for the current global market for various industries and set its benchmark in the market research industry. We have a large support of database from various leading organizations and business executives across the globe; so, we excel at customized report as per the clients requirements and updating market research report on the daily basis with quality information.

Contact Info:

Name: Alex Mathews

Address: 500 East E Street, Ontario,

CA 91764, United States.

Phone No: USA: +1 909 414 1393

Email:[emailprotected]

Website:https://dataintelo.com

Read the original:
Computational Immunology Market 2021 Is Rapidly Increasing Worldwide in Near Future | Top Companies Analysis- EpiVax, Novozymes Biopharma, ioGenetics,...

Insulin100 symposium to draw world experts in diabetes research and care – News@UofT

What can pancreas cell transplants do for people living with diabetes today? How are new technologies allowing women to better manage diabetes during pregnancy? Could science soon prevent type 1 diabetes altogether?

These are just a few questions diabetes experts from around the world have tackled in a series of online educational presentations celebrating the 100th anniversary of the discovery of insulin at the University of Toronto.

The presentations are free and available to anyone who registers for the universitysInsulin100 Scientific Symposium, which will culminate in live online panel discussions on April 15 and 16. More than 4,500 people have registered for the event, which focuses on management of diabetes and its complications, tips for improving patient care and translation of recent research into practice.

Its gratifying to see the interest, which has really come from around the world, saidDaniel Drucker, chair of the symposium organizing committee anda professor in the department of medicine at theTemerty Faculty of Medicine, and a senior investigator at theLunenfeld-Tanenbaum Research Instituteat Sinai Health.

It was a bit disappointing to go virtual after years of planning, but the upside is were reaching thousands, not hundreds.

Drucker, who recently received the Gairdner International Award for his research,said feedback on the recorded presentations has been positive, with many expressing appreciation for the brevity of the talks they average about 25 minutes and the fact they are delivered by world experts.

Daniel Drucker, chair of the Insulin100 Scientific Symposium organizing committee anda professor in the department of medicine, says the online format of the event means it will reach thousands of people instead of hundreds (photo by Johnny Guatto)

The journal of the European Association for the Study of Diabetes,Diabetologia, has selected 13 of the symposium speakers to write review articles and is posting them with links to the Insulin100 videos.

The live discussions will feature many of the same speakers, with each panel moderated by a U of T faculty member and a trainee.

Topics on the first day will include the discovery of insulin, advances in beta cell and islet auto-immunity, and the use of insulin in the real world. The latter event will be hosted by Jacqueline James, a professor in the department of medicine, and featuresfour speakers:

The live event will also showcase young researchers. Four early career investigators will receive awards that recognize and support their work, including Imperial College of Londons Steven Millership,Rebecca CheungandGrazia Pizza, McMaster Universitys Marie Pigeyre andAviroop Biswas, an assistant professor at U of TsDalla Lana School of Public Health.

Eight post-doctoral researchersand graduate students will present their research and receive awards to fund their studies.

Saad Khan, one of theaward recipients,is a fourth-year doctoral student inimmunologywho studies links among the immune system, inflammation and obesity in metabolic diseases.

Khan and his colleagues recently found that B cells that reside in the gut and liver contribute to obesity-related insulin resistance in mice. He will present these results along with further findings that connect this work to intestinal permeability, pathogenic bacteria and non-alcoholic fatty liver disease in patients.

The event is a platform to showcase the research Ive been working on for several years, so Im excited about that, said Khan, whose academic supervisor isDaniel Winer, an assistant professor of bothlaboratory medicine and pathobiology, and immunology with a lab atUniversity Health Network.

Khan said he will attend the live panels on both days and is looking forward to the intensive educational experience they offer.

Toronto is a great place for new frontiers in research on diabetes and metabolism, and I love the story of Banting and Best, Khan said. As a graduate student and a Canadian, its highly motivational.

Read more from the original source:
Insulin100 symposium to draw world experts in diabetes research and care - News@UofT

Immunology Market Analysis by Size, Sales, Competitive landscape and Forecast to 2026 The Bisouv Network – The Bisouv Network

The Immunology Market study is a perfect mix of qualitative and quantitative information and to get better understanding on how stats relates to growth, market sizing and share, the study is started with market overview and further detailed commentary is showcased on changing market dynamics that includes Influencing trends by regions, growth drivers, long term opportunities and short term challenges that industry players are facing. Furthermore, Market Factor Analysis gives insights on how various regulatory affairs, economic factors and policy action are factored in the past and future growth scenarios by various business segments and applications. The Competitive Landscape provides detailed company profiling of players and draws attention on development activities, swot, financial outlook and major business strategic action taken by players. Players that are in the coverage of this study, some of them are Novartis AG, UCB SA, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, AbbVie Inc., Amgen Inc., ALLERGAN, Astellas, Janssen Global Services, LLC (Johnson & Johnson), Other Prominent Players, Pfizer Inc. & Merck Sharp & Dohme Corp..

Industries and markets are ever-evolving; navigate these changes with ongoing research conducted by HTF MI; Address the latest insights released on Global Immunology Market.Get Free Sample Report + All Related Graphs & Charts @:https://www.htfmarketreport.com/sample-report/3186539-global-immunology-market

Relevant features of the study that are being offered with major highlights from the report :

1) Can Market be broken down by different set of application and types?Additional segmentation / Market breakdown is possible subject to data availability, feasibility and depending upon timeline and toughness of survey. However a detailed requirement needs to be prepared before making any final confirmation.

** An additional country of your interest can be included at no added cost feasibility test would be conducted by Analyst team of HTF based on the requirement shared and accordingly deliverable time will also be disclosed.

2) How Study Have Considered the Impact of Economic Slowdown of 2020 ?Analyst at HTF MI have conducted special survey and have connected with opinion leaders and Industry experts from various region to minutely understand impact on growth as well as local reforms to fight the situation. A special chapter in the study presents Impact and Market factor Analysis on Global Immunology Market along with tables and graphs related to various country and segments showcasing impact on growth trends.

3) Which companies are profiled in current version of the report? Can list of players be customize based on regional geographies we are targetingConsidering heat map analysis and based on market buzz or voice the profiled list of companies in the the report are Novartis AG, UCB SA, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, AbbVie Inc., Amgen Inc., ALLERGAN, Astellas, Janssen Global Services, LLC (Johnson & Johnson), Other Prominent Players, Pfizer Inc. & Merck Sharp & Dohme Corp.. Yes, further list of players can also be customized as per your requirement keeping in mind your areas of interest and adding local emerging players and leaders from targeted geography.

** List of companies covered may vary in the final report subject to Name Change / Merger & Acquisition Activity etc. based on the difficulty of survey since data availability needs to be confirmed by research team specially in case of privately held company. Up to 2 players can be added at no additional cost.

Enquire for making customized Report @https://www.htfmarketreport.com/enquiry-before-buy/3186539-global-immunology-market

To comprehend Global Immunology market dynamics in the global market, the worldwide Immunology market is analyzed across major geographical regions. HTF Market Intelligence also provides customized specific regional and country-level reports, see below break-ups.

North America: United States, Canada, and Mexico. South & Central America: Argentina, ,Chile, LATAM, and Brazil. Middle East & Africa: Saudi Arabia, UAE, Israel, Turkey, Egypt and South Africa. Europe: UK, France, Italy, Germany, Spain, BeNeLux, and Russia. Asia-Pacific: India, China, Japan, South Korea, Indonesia, Thailand, Singapore, and Australia.

2-Page company profiles for 10+ leading players is included with 3 years financial history to illustrate the recent performance of the market. Latest and updated discussion for 2019 major macro and micro elements influencing market and impacting the sector are also provided with a thought-provoking qualitative remarks on future opportunities and likely threats. The study is a mix of both statistically relevant quantitative data from the industry, coupled with insightful qualitative comment and analysis from Industry experts and consultants.

Global Immunology Product Types In-Depth: , Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammatory Bowel Disease & Prophylaxis of Organ Rejection

Global Immunology Major Applications/End users: Hospital Pharmacies, Retail Pharmacies & Online Pharmacies

Market Sizing by Geographical Break-down: North America (Covered in Chapter 9), United States, Canada, Mexico, Europe (Covered in Chapter 10), Germany, UK, France, Italy, Spain, Russia, Others, Asia-Pacific (Covered in Chapter 11), China, Japan, South Korea, Australia, India, South America (Covered in Chapter 12), Brazil, Argentina, Columbia, Middle East and Africa (Covered in Chapter 13), UAE, Egypt & South Africa

To ascertain a deeper view of Market Size, competitive landscape is provided i.e. Comparative Market Share Revenue Analysis (Million USD) by Players (2019-2020) & Segment Market Share (%) by Players (2019-2020) and further a qualitative analysis of all players is made to understand market concentration rate.

Competitive Landscape & Analysis:Major players of Immunology Market are focusing highly on innovation in new technologies to improve production efficiency and re-arrange product lifecycle. Long-term growth opportunities for this sector are captured by ensuring ongoing process improvements of related players following NAICS standard by understanding their financial flexibility to invest in the optimal strategies. Company profile section of players such as Novartis AG, UCB SA, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, AbbVie Inc., Amgen Inc., ALLERGAN, Astellas, Janssen Global Services, LLC (Johnson & Johnson), Other Prominent Players, Pfizer Inc. & Merck Sharp & Dohme Corp. includes vital information like legal name, website, headquarter, its market position, distribution and marketing channels, historical background and top 4 closest competitors by Market capitalization / turnover along with sales contact information. Each company / manufacturers revenue figures, growth rate, net profit and gross profit margin is provided in easy to understand tabular format for past 3 years and a separate section on market entropy covering recent development activities like mergers &acquisition, new product/service launch, funding activity etc.

Get Latest Edition of Global Immunology Market Study at Revised offered Price

In this study, the years considered to estimate the market size of Global Immunology are as follows:History Year: 2014-2019, Base Year: 2019, Forecast Year 2021 to 2026

Key Stakeholders / Target Audience Covered:In order to better analyze value chain/ supply chain of the Industry, a lot of attention given to backward & forward Integration Immunology Manufacturers Immunology Distributors/Traders/Wholesalers Immunology Sub-component Manufacturers Industry Association Downstream Vendors

Actual Numbers & In-Depth Analysis of Immunology Market Size Estimation, Business opportunities, Available in Full Report.

Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, LATAM, West Europe, MENA Countries, Southeast Asia or Asia Pacific.

Contact US :Craig Francis (PR & Marketing Manager)HTF Market Intelligence Consulting Private LimitedUnit No. 429, Parsonage Road Edison, NJNew Jersey USA 08837Phone: +1 (206) 317 1218[emailprotected]

Connect with us atLinkedIn|Facebook|Twitter

Visit link:
Immunology Market Analysis by Size, Sales, Competitive landscape and Forecast to 2026 The Bisouv Network - The Bisouv Network

Weight loss story: Here’s how this student used nutritional biochemistry to lose weight fast" | The Times of India – Times of India

I followed the principles of Intermittent Fasting for weight loss. I used to maintain a 16-hour gap between my dinner and brunch and then, a 6-hour gap between brunch and dinner.

My breakfast: I only have two glasses of warm water in the morning.

Even now, when I have achieved 4% body fat, I still follow the eating pattern, it's like a ritual for me. I feel it's the best way to keep our metabolism in shape, without starving or avoiding certain foods.

My lunch: I had to lose a considerable amount of fat so I had to keep a strict regime on my calories intake. With the knowledge of nutrition, I calculated that I needed 1500kcal/day to achieve the goal. So, I took 750kcal from my lunch and 750kcal from my dinner.

It consisted of 2 chapatis, 1 cup daal, 1 cup of green vegetables and 100 gm of unpolished rice. I never believed in the concept that carbs are harmful for weight loss. Each macro is important and equally beneficial, we just have to create a balance in our input.

My dinner: 2 chapatis, 1 cup daal, green veggies and 1 glass of unsweetened milk at the time of going to bed.

Pre-workout meal: A cup of black coffee with no sugar.

Post-workout meal: After the workout, I just hydrate my body so that it can utilize all the fat oxidation properly.

I indulge in (What you eat on your cheat days): I used to have non-veg food on cheat days. I ate chicken curry, fish on my cheat days. Also, I took higher calories by 300kcal on these days. A regulated cheat day is very helpful in balancing the set point of the metabolism.

Low-calorie recipes I swear by: Daal is best for our body. It not only helps in Ketosis but also keeps us full for a longer time.

Read the original here:
Weight loss story: Here's how this student used nutritional biochemistry to lose weight fast" | The Times of India - Times of India

Students, Faculty Respond to Discrimination Allegations within Oberlin STEM – The Oberlin Review

Two weeks ago, the Biochemistry Department hosted a listening session to allow students to share concerns about diversity and inclusion within the department. The meeting came after an opinions piece published in the Review elicited a strong reaction from students, faculty, and alumni.

In the original article, College fourth-year Ritesh Isuri discussed their experiences with racial and gender-based discrimination in the Biochemistry and Physics departments. According to Isuri, they have received over 300 messages from students and alumni who resonated with their story.

I think one thing that was really surprising to me is the sheer amount of emails, Isuri said. Ive got messages and texts as responses from students. [Students and alumni] have been telling me Im not the only one; theyre also having issues like that. And they did share a few personal stories with me. Its just insane to think 300 students have reached out about these things and that so many of them are alumni. So how long has this been going on?

Howard Hughes Medical Institute STEM Fellow Marcus Hill, OC 19, held the listening session to learn more about students concerns. HHMI is a grant program at Oberlin College committed to addressing inequity in the sciences.

There were stories of students who felt like they had experienced a microaggression at best or something more severe at worst wanting to see change, Hill said. I think so much of that problem exists because of the boundaries and the communication that we have.

After the listening session, Hill developed ideas that he could bring to faculty to enhance discussions around equity in the department. He plans to meet with the faculty to share student concerns and encourage faculty to incorporate discussions of inclusivity inside the classroom.

In addition to eliciting responses from students, Isuris op-ed also garnered the attention of faculty. Some were surprised when they read the article because they were unaware of the discriminatory treatment within Oberlin academic departments.

Im really close to my professors, which is why they were shocked when I told them about these things, Isuri said. They were like, Oh, Im close to you. I did not know you had to go through all these things at Oberlin. It is insane, but I am not alone, this happens to everybody to everybody who looks like me. Although I was disappointed with the initial surprise, I just think they needed the time to process it. And now what Im seeing is they are willing to take actions. Im happy about that.

After digesting this information, faculty have committed to making changes to ensure that the Biochemistry department is more inclusive including changes that specifically respond to the concerns voiced by international students.

We never want to see students in bad situations, said Associate Professor and Chair of Chemistry and Biochemistry and HHMI Program Director Jason Belitsky. I think everyone on the faculty responded in that way; we wanted to do whatever we can to make the department as welcoming and inclusive as possible and avoid any negative situations that have happened in the past or are still happening.

The Biochemistry department has promised to expand research opportunities, review departmental awards, and bolster general support for international students. The department is also planning an alumni listening session with the hope that former students will feel more comfortable speaking to faculty about problems in the department.

Other STEM departments are also examining their practices. This past year, three departments have established Departmental Action and Reflection Teams, an HHMI process aimed at improving inclusivity in STEM. Next year, another four departments will assemble DARTs, including Biochemistry.

Hill hopes that DART will give departments more tools to have these kinds of conversations next year. Departments that went through the DART process this year were able to enact changes to improve inclusivity for example, Geology strengthened the student representatives role in the department and instituted a more democratic process for their election.

Isuris op-ed resonated with Yasmine Ramachandra, OC 19, who hopes that the article will continue to spark dialogue.

It reflected a lot of my experiences and also just affirms how I felt while I was at Oberlin, Ramachandra said. Previously, when I had talked about things, it was always within the department, and it was never some external force putting pressure on the department, which is why I really appreciated what [Isuri] wrote.

Going forward, Ramachandra hopes to see continued changes. She believes that STEM departments should focus on recruiting more students of color, specifically Black students, and create a more permanent position for diversity and inclusion than the current HHMI fellowship.

Additionally, Ramachandra believes that there is a need for more avenues to hold students and professors accountable for their actions. While the Office of Equity, Diversity, and Inclusion exists to help students report instances of racism, not all students are aware of this resource.

[In the Geology department,] I know there are conversations about making more obvious ways of reporting any discomfort going on in the department, whether its with a particular professor or student, or if theres unsafe lab practices that you want to address, Hill said. Obviously the College promotes going to Title IX, if there are those sorts of things. But besides that, I dont know that there is any sort of process laid out of how to bring these up in a way that that feels appropriate.

For students, the patchwork set of processes for getting help might include talking to Hill directly, reaching out to a trusted faculty member, or talking to other students. Faculty often hear about incidents secondhand or thirdhand.

Ive opened up chair office hours, Belitsky said. Thats one avenue, but I think thats definitely something for us to work on is to have better routes of communication for different concerns.

Reporting problems to a department chair can often be difficult because of a chairs close relationship with their faculty members, as well as the lack of protocol around accountability measures. Additionally, some students may hesitate to speak to department chairs because they are concerned about retaliation. Ramachandra spoke to a negative experience that she had in conversation with a professor.

There was one point where I complained multiple times about a professor who is no longer at Oberlin, Ramachandra said. I remember trying to go to office hours to get feedback on a test and [earn] points back when my answer was the exact same as my friends answers who got full credit, and I didnt get any credit. That professor was so disrespectful to me and alluded to things that I had brought up when meeting with the department head at the time. So I know that this particular professor had heard what I said, and I felt like it was being thrown back in my face.

For Ramachandra, this conversation was exemplary of her experience trying to confront issues in Oberlins STEM departments.

It felt like they were saying, Im not going to help you because you complained about me, she said. But the thing is that when I bring up criticism, its not because I want someone fired; its because I want to see action being taken, whether its a conversation or disciplinary action.

Concerns about retaliation are especially salient for students in STEM departments who need strong grades and letters of recommendation to apply for graduate school. For international students, grad school acceptances or job offers are often essential to ensure their immigration status allows them to stay in the U.S. after graduation.

I also wish [departments] had some sort of process that outlines the steps [professors] need to take when they treat their students differently and these [steps] are like disciplinary actions, Ramachandra said. I just dont see a ton of policy [for] accountability. I see a start of conversations about accountability, but theres nothing really integrated into the foundation of the department yet.

If a student has experienced discrimination they are encouraged to report their experience to the College using this link. Students are also invited to share their experiences with the Review at [emailprotected].

Continued here:
Students, Faculty Respond to Discrimination Allegations within Oberlin STEM - The Oberlin Review

Global Electrolyte and Biochemistry Analyzers Market 2020 Key Players Analysis, Competitive Landscape and Forecast to 2025 KSU | The Sentinel…

The research study on Global Electrolyte and Biochemistry Analyzers Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 brings to light the excellent research on the market overview. The report offers a primary focus on influential factors in the global Electrolyte and Biochemistry Analyzers industry. The report includes insightful information about pricing, cost, value, capacity, gross revenue, and profit margins with reference to historical analysis and forecast estimation for the 2021 to 2026 time period. It presents a close overview of the markets major drivers, restraints, challenges, opportunities and current market trends, the supply chain and share market, and strategies impacting the global market along with estimates and forecast of revenue and share analysis.

The report firstly contains a broad introduction of the global Electrolyte and Biochemistry Analyzers market and then analyses specific segments such as application, regional markets, end-users, value chain structure, and emerging trends. It offers a comprehensive analysis of the global Electrolyte and Biochemistry Analyzers market inclusive of product portfolio, categories, applications, and a comprehensive analysis of the value chain structure. The report studies the dynamics of the market, the changing competition landscape, and the flow of the global supply and consumption.

NOTE: Our report highlights the major issues and hazards that companies might come across due to the unprecedented outbreak of COVID-19.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketquest.biz/sample-request/26325

Trending Factors Influencing the Market Shares:

There are various dynamic features of the business, like client need and feedback from the customers. The report has studied in-depth from all dynamic aspects such as industrial structure, application, classification, and definition. The report gives an in-depth view to the readers, detailed geographical segmentation within the global market has been covered in this study. The market research report predicts the size of the global Electrolyte and Biochemistry Analyzers market with respect to the information on key merchant revenues, development of the industry by upstream and downstream, industry progress, key companies, along with market segments and application.

The global market competitive scenario and participants detailed profiles: Roche, ThermoFisher, Abbott, Danaher, Mindray, Siemens, Senlo, Horiba Medical, Hitachi, Shanghai Kehua Bio-Engineering Co., Ltd, URIT Medical Electronic, Shenzhen Rayto, Sunostik, Meizhou Cornley, Randox Laboratories, Jiangxi TECom, ELITec Group, Convergent Technologies, Dirui, Sysmex, SFRI, Diestro, Nova Biomedical, Idexx Laboratories, Shenzhen Genius Biotech Inc, Hycel Medical, Sensa Core, Caretium, Medica, Erba Mannheim

The most important types of products covered in this report are: Electrolyte Analyzers, Biochemistry Analyzers

The most widely used downstream fields of market covered in this report are: Hospital, Clinic, Labs, Others

Each geographic segment of the global Electrolyte and Biochemistry Analyzers market has been independently surveyed along with pricing, distribution, and demand data for geographic market notably: North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia, Italy, Spain, Benelux, Nordic), Asia (China, Japan, Korea, India, Southeast Asia, Australia and Taiwan), South America (Brazil, Argentina), MENA (Saudi Arabia, UAE, Turkey)

ACCESS FULL REPORT: https://www.marketquest.biz/report/26325/global-electrolyte-and-biochemistry-analyzers-market-2020-by-manufacturers-regions-type-and-application-forecast-to-2025

Regional Profile:

The market can delve into crucial assessment and substantial market-specific deductions that are deployed to ensure remarkable growth progression despite rigid competition and market volatility. Regional assessment of the global Electrolyte and Biochemistry Analyzers market reveals untapped opportunities in regional and domestic market places. Here, the size and CAGR of the regional markets are also provided.

Customization of the Report:

This report can be customized to meet the clients requirements. Please connect with our sales team ([emailprotected]), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: [emailprotected]Web: http://www.marketquest.biz

Continued here:
Global Electrolyte and Biochemistry Analyzers Market 2020 Key Players Analysis, Competitive Landscape and Forecast to 2025 KSU | The Sentinel...

Study Report on Electrolyte and Biochemistry Analyzers Market Research, Developments, Expansion, Statistics, Alternatives & Forecast To 2027 |…

The global Electrolyte and Biochemistry Analyzersmarketis comprehensively and Insightful information in the report, taking into consideration various factors such as competition, regional growth, segmentation, and Electrolyte and Biochemistry AnalyzersMarket size by value and volume. This is an excellent research study specially compiled to provide the latest insights into critical aspects of the Electrolyte and Biochemistry Analyzersmarket. The report includes different market forecasts related to market size, production, revenue, consumption, CAGR, gross margin, price, and other key factors.It is prepared with the use of industry-best primary and secondary research methodologies and tools.

TheMajorPlayers Covered in this Report:etc.& More.

In 2019, the global Electrolyte and Biochemistry Analyzers market size was million US$ and it is expected to reach a million US$ by the end of 2027, with a CAGR between 2021 and 2027.

Get a Sample PDF Report:http://marketresearchvision.com/request-sample/562784

This report studies the Electrolyte and Biochemistry Analyzers market size by players, regions, product types, and end industries, history data 2014-2019, and forecast data 2021-2027; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porters Five Forces Analysis.

Segment by TypeElectrolyte AnalyzersBiochemistry Analyzers

Segment by ApplicationHospitalClinicLabsOthers

Global Electrolyte and Biochemistry Analyzers

Each section of the report reveals critical information about the global Electrolyte and Biochemistry Analyzers market that could be used to ensure strong growth in the coming years. Our unique blend of primary and secondary research techniques helped us to recognize hidden business opportunities available in the global Electrolyte and Biochemistry Analyzersmarket, besides collecting significant insights of market participants and obtaining precise market data.It includes several research studies such as manufacturing cost analysis, absolute dollar opportunity, pricing analysis, company profiling, production and consumption analysis, and market dynamics.

Regional Analysis For Electrolyte and Biochemistry Analyzers Market:

North America(United States, Canada, and Mexico)Europe(Germany, France, UK, Russia, and Italy)Asia-Pacific(China, Japan, Korea, India, and Southeast Asia)South America(Brazil, Argentina, Colombia, etc.)Middle East and Africa(Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

In this study, the years considered to estimate the market size of the Electrolyte and Biochemistry Analyzers are as follows:

Grab Your Report at an Impressive Discount! Please click Here@http://marketresearchvision.com/check-discount/562784

The study objectives of this report are:

For More Details On this Report:https://www.marketresearchvision.com/reports/562784/Electrolyte-and-Biochemistry-Analyzers-Market

To conclude, the Electrolyte and Biochemistry Analyzers Industry report mentions the key geographies, market landscapes alongside the product price, revenue, volume, production, supply, demand, market growth rate, and forecast, etc. This report also provides SWOT analysis, investment feasibility analysis, and investment return analysis.

Contact UsMr. Elvis FernandesPhone:+1 513 549 5911 (US)+44 203 318 3219 (UK)Email: sales@marketresearchvision.com

View original post here:
Study Report on Electrolyte and Biochemistry Analyzers Market Research, Developments, Expansion, Statistics, Alternatives & Forecast To 2027 |...